Randox provides Team GB’s COVID testing for Beijing Winter Olympic Games
Randox provides Team GB’s COVID testing for Beijing Winter Olympic Games
Tuesday 01 February 2022
Gold standard testing for Great Britain’s Olympians: Randox provides Team GB’s COVID-19 testing for Beijing Winter Olympic Games
As part of the two-year partnership between Randox and The British Olympic Association, the Team GB Olympians competing in the Olympic Winter Games 2022 have used Randox COVID-19 tests to ensure they touch down in Beijing free of COVID and have the best possibility opportunity to compete without the fear of being ruled out on health grounds.
The ‘stop the virus’ logistics drive mirrors a similar and highly successful regime which ensured that Team GB landed in Japan for the 2020 Olympic Games COVID-free, and that no athlete was forced to withdraw in Tokyo because of infection or close contact with someone who had tested positive.
Despite fears that the virus could impact Team GB’s Olympic hopes, the rigorous testing programme put in place helped UK sporting stars to rack up 54 medals – their best-ever performance at an overseas Games bar the 67 medals won in Rio in 2016.
To provide its gold-standard PCR testing services, Randox created a bespoke dashboard for Team GB to register its samples, which will be taken by the Team GB Clinical Team and then transported to the company’s laboratories which are located in Manchester, Greater London and Northern Ireland.
Randox is testing a delegation of 200 Olympians, coaches and support staff in order to meet China’s testing requirements and thereby minimising possible transmission of the virus in Beijing. Randox is providing each member of Team GB with four rounds of pre-departure tests and can offer rapid same-day testing on the day of flying as an extra precaution.
At the time of the announcement of the partnership between Randox and the British Olympic Association, in June 2021, Randox Managing Director, Dr Peter FitzGerald, said:
“We are delighted to be supporting Team GB by helping them get safely to the starting line in Tokyo with our premium Covid-19 testing services, the provision of which has been a major focus of ours since the outbreak of the pandemic. Over the last year, we have been investing significantly in our customer service and testing capacity, which means Randox can now process over 500,000 tests per day, making it the largest laboratory in Europe, and to date has processed over 13 (now 23) million tests. For this reason, our Olympians and anyone else who needs to travel internationally can rest assured that they will receive timely results.”
British Olympic Association CEO, Andy Anson, said:
“This is a fantastic and vital partnership for Team GB ahead of Tokyo 2020 and Beijing 2022. We have committed to our hosts in Japan and the IOC to ensure that our delegation is fully vaccinated and are also ensuring we have enhanced Covid testing in place. Randox’s pedigree in this area gives us great confidence that we are providing athletes with the best possible medical support around Covid testing and that they get to the start line safely ready to compete successfully for the biggest moment of their sporting careers.”
Randox, with almost 40 years of international diagnostics experience, has been at the forefront of COVID-19 testing since the outset of the pandemic. With proven testing capability and well-established logistics and customer support services, Randox are strongly placed to allow international travellers to travel with confidence.
Pictured with a Randox COVID-19 Predeparture Test is English freestyle skier Katie Summerhayes
For further information on Covid testing services please contact the Randox Covid Customer Support team on 028 9434 3005.
For press enquiries please contact Amy Millar in the Randox PR team: randoxpr@randox.com
Want to know more?
Contact us or visit Randox Health.
Related COVID-19 Products and Services
HOME TEST
ANTIBODY TEST
TEST TO RELEASE
LABORATORY TOOLS
Randox and PayPoint partner to boost accessibility of Day 2 lateral flow tests
The updated collaboration opens up PayPoint’s extensive retail network to offer increased convenience to travellers returning to the UK
Randox and PayPoint have today announced an expansion of their partnership, to boost access to COVID-19 testing and provide a vital service to travellers returning to the UK, in line with the Government’s new arrival requirements for Day 2 testing, announced on Wednesday 5th January.
The expanded partnership between PayPoint and Randox will mean even easier access to low-cost COVID-19 testing, by enabling people to order a Randox test online for click and collect at a local store within the Collect+ network, initially available in over 5,000 locations, and soon in over 10,000 locations nationwide.
The service launches on 7th January 2022 to coincide with changes to travel policy which, from 4am on 9th January, allows fully vaccinated arrivals from non-red list countries to take a lateral flow (antigen) test, with a PCR test only required if a positive lateral flow result is returned.
In addition, from mid-January, PayPoint will give consumers the ability to walk into a local store and pick up a test immediately in over 2,500 locations, with no need to order online. This service will be offered in partnership with major convenience retailers including Scotmid Co-operative and Spar in the North West and Scotland.
Dr Peter FitzGerald, Managing Director at Randox said: “By drawing on our 40 years’ diagnostics experience, unparalleled testing capacity, and well-established logistics network, which now includes an extensive number of new locations from PayPoint, Randox is able to respond quickly to changing travel requirements and simplify the process of ordering Day 2 lateral flow tests.
“The availability of value for money tests that can be collected at the customer’s convenience thanks to our partnership with PayPoint means people in the UK don’t need to wait for home delivery or a walk-in clinic appointment when ordering a COVID-19 test.”
Nick Wiles, Chief Executive at PayPoint said: “Our expanded partnership with Randox will deliver yet another vital service to help keep people safe in communities across the UK. Consumer convenience and accessibility are at the very heart of what we do and this is another example of our agility, responsiveness and the great relationships we have with our retailer partners in the ever-changing landscape across the UK.”
Day 2 lateral flow tests must be ordered before travel to England and can be ordered from 4am on 7th January. Thanks to the updated collaboration between PayPoint and Randox, people can now conveniently collect these tests from local stores for just £18.95, rather than waiting at home for deliveries to arrive.
Using the free Randox CertiFly App results are processed within 3 hours and a report delivered in-app and via email, allowing arrivals into England to complete their Day 2 test conveniently in the comfort of their own home, and for individuals who test positive, potentially reducing the amount of time they need to isolate.
Visit covid.randox.com to purchase COVID-19 tests from Randox Health.
Related COVID-19 Products and Services
CERTIFLY LATERAL FLOW
HOME TEST - PCR
ANTIBODY TEST
LABORATORY TOOLS
Randox Health launches COVID-19 Travel Centre in Enniskillen
25th November 2021: Randox Health launches COVID-19 Travel Centre in Enniskillen
A COVID-19 Testing Service launches this week in a new Randox Health Travel Centre in Enniskillen, offering COVID tests from just £30.
The testing service from Randox, a laboratory partner in the UK’s National COVID-19 Testing Programme, offers rapid lateral flow (LFD) tests – with results in just 60 minutes – for those who are eligible to take an LFD for their Day 2 testing requirements.
The service in Enniskillen will also provide gold-standard PCR testing for those who need it for pre-departure screening, on-arrival testing on Day 2 and Day 8, or simply for peace of mind, with Express PCR tests returning results in as little as 3 hours.
Sophie Boyd, Project Manager for the Randox COVID-19 Testing Service, explained;
“In addition to our Travel Centres at Belfast International Airport, Belfast City Airport, Holywood and Crumlin, we are pleased to expand our testing service to Enniskillen, to serve the Fermanagh area with our accurate and cost-effective COVID-19 tests.
“Whilst travel guidance during the pandemic continues to evolve, testing will remain a key part of the response to COVID-19 – not only to identify outbreaks, isolate cases and prevent further spread, but also to assist with a return to social and economic normality.”
From 4am on 31st October 2021, changes to travel guidance for those arriving in Northern Ireland from countries not on the red list came into effect.
For vaccinated passengers, lateral flow (antigen) tests may now be used for post-arrival testing as an alternative to PCR testing, with a photograph of the completed lateral flow test required in order to verify the result.
Sophie continued;
“In support of changes to government travel guidance, our COVID-19 testing service has evolved to now include lateral flow testing in addition to our gold-standard PCR testing, and Randox is recognised as a provider of both services on the official government list.
“Randox is committed to providing competitive, effective and efficient testing to support holidaymakers and those undertaking international travel and the opening of the Randox Health Travel Centre in Enniskillen is another positive step towards the normalization of travel and other social activities.”
The Randox Health Travel Centre in Enniskillen is open to all asymptomatic individuals and is conveniently located on the Tempo Road.
Randox COVID Testing is also available at Randox Health Travel Centres at Belfast International Airport and Belfast City Airport, and in Randox Health Clinics in Holywood and Crumlin.
Visit booking.randox.com to book your appointment. Prices are included below.
| Service | Price |
| PCR Next Day (Result before 11:59pm) | £55 |
| PCR Express (Results in 1-3 hours) COMING SOON | £90 |
| Antigen Rapid Test | £30 |
| Day 2 PCR | £55 |
| Day 8 PCR | £55 |
| Day 2 Antigen | £35 |
Related COVID-19 Products and Services
CERTIFLY LATERAL FLOW
HOME TEST - PCR
ANTIBODY TEST
LABORATORY TOOLS
Randox and Collect+ join forces to boost accessibility of reduced-cost PCR and Lateral Flow tests
25th October 2021: Randox and Collect+ join forces to boost accessibility of reduced-cost PCR and Lateral Flow tests
Today, Randox and Collect+ announce a new partnership that will provide even easier, nationwide access to low-cost COVID-19 testing. The partnership enables consumers to order a new reduced-cost PCR (£34.99) or lateral flow (£19.99) test online and then pick it up on the same day from participating shopping centres within the Collect+ network. This first of its kind partnership means people in the UK no longer need to wait for a home delivery or walk-in clinic access when ordering a COVID-19 test.
With an initial 29 locations already open, this collaboration plans to expand to more than 100 Collect+ locations in the coming weeks, and hopes to go further to utilise even more of the Collect+ network over the medium to longer term. Randox’s collaboration with Collect+ has not only simplified the logistics process but has sought to help support their retailer partners and provide another vital service at the heart of local communities.
In recognition of changes to travel guidelines for England, which state that from 24th October, fully vaccinated passengers from non-red list countries can take a lateral flow test for their day-two post-arrival checks, Randox now offers home testing kits as both PCR and lateral flow, to aid pre-departure testing and any current and future day 2 requirements. PCR and lateral flow tests are available at the newly reduced prices of £34.99 and £19.99 respectively when using Collect+ click and collect.
Philip Robinson, VP Sales at Randox said: “As guidelines change and the country continues to open up, Randox is able to support any travel testing requirements by utilising our extensive diagnostics experience and logistics network, and offering value for money for both PCR and lateral flow tests that can be collected at the customer’s convenience thanks to our new partnership with the Collect + service from PayPoint.
“Our significant investment in capacity expansion and in logistics solutions such as Collect + click and collect sites that further simplify the process of ordering COVID-19 tests, have allowed us to make ongoing price reductions, demonstrating our commitment to helping people live their lives as easily and normally as possible.”
Nick Williams, Head of Strategic Partners & Product, Collect+ said: “This is an exciting and important partnership for Collect+, which has always had consumer convenience and accessibility at the very heart of its operations. Randox has been instrumental in making COVID-19 tests easily available to people around the UK and this collaboration will see that country wide impact become even more meaningful.”
As Randox remains amongst the very largest COVID-19 laboratories in the UK and Europe and to date has processed almost 20 million tests, facilitated by drive-thru services, in-person clinics and home delivery options, the introduction of Collect+ locations further diversifies the efforts made by the company to make testing more accessible.
The number of Randox shopping centres with Randox Collect + locations now totals 29, including but not limited to Liverpool ONE, Waterloo Station, Brent Cross London, and Festival Place Basingstoke.
Neil Churchill, Centre Director, Festival Place Shopping Centre, commented:
“The Randox click and collect service is a good illustration of Festival Place’s growing position as an all-day destination, offering a variety of services to complement the traditional retail offer. Our Guest Services team have noted an increase in visitors, from all across Europe, passing through Festival Place to collect the Randox kits required for their travel. Customers appreciate the option to pick up their kits close to home while able to do their shopping at the same time.”
For further information on our new Click and Collect service please click here.
For press enquiries please contact Amy Millar, Randox Public Relations Team Leader; amy.millar@randox.com or 028 9442 2413
Related COVID-19 Products and Services
CERTIFLY LATERAL FLOW
HOME TEST - PCR
ANTIBODY TEST
LABORATORY TOOLS
Randox listed on Gov.uk as provider of Day 2 Lateral Flow COVID tests
22nd October 2021: Randox listed on Gov.uk as provider of Day 2 Lateral Flow COVID tests
Following changes to government travel guidance, lateral flow (antigen) tests will be the Day 2 requirement for any fully vaccinated passengers arriving into England, from 24th October. This change applies only to fully vaccinated international travellers and most under 18s arriving into England from non-red list countries, and will replace the previous PCR testing requirement.
This change will come into effect for anyone returning into England, following the half-term break and tests can be completed on or before day two of their arrival.
Randox is listed on Gov.uk as a provider of Day 2 Lateral Flow COVID tests.
Randox offers multiple lateral flow testing solutions, including the new Randox CertiFly rapid antigen test, which will allow you to complete your Day 2 test in the comfort of your own home from only £19.99.
The Randox CertiFly Lateral Flow test is designed to simplify foreign travel for passengers and facilitate the efficient transfer of secure and verified information through an easy to use mobile app.
Available for free through the App Store and coming soon on Google Play, the app securely identifies customers and processes testing results within 3 hours.
To order a Lateral Flow Home Testing Kit visit https://covid.randox.com/day-2-test-at-home/
If your preference is to take your Day 2 test on arrival at the airport then you have the option of visiting one of our many travel centres conveniently located across the UK.
From £35 you can organise for a Sample Collection Officer to take your swab at clinics including Manchester Airport, Heathrow Airport, Stansted Airport, East Midlands Airport, Liverpool ONE, and Waterloo Station London.
To book an in-clinic Day 2 Lateral Flow appointment visit https://covid.randox.com/day-2-test-in-clinic/
Background to Government changes
Eligible fully vaccinated arrivals and those with an approved vaccine from non-red countries will be able to replace the test taken as soon as possible on arrival, referred to as the Day 2 PCR test, with a self-administered lateral flow device (“LFD”). Arrivals must have had a complete course of a recognised vaccine at least 14 days before arriving in England. They will not be required to take a Pre-Departure Test or a Day 8 test.
Passengers who do not meet the “eligible traveller” criteria will still have to take a pre-departure test, a Day 2 and Day 8 PCR test and self-isolate for 10 days upon their return from a non-red list country. Test to Release will remain an option for unvaccinated passengers who wish to shorten their isolation period.
How will the new lateral flow system work?
Passengers will be required to take a photograph of their completed lateral flow test alongside their booking reference number which Randox will provide via email on receipt of order. Randox will then verify the result of your sample. Passengers will still be required to complete a passenger locator form to return to England.
Anyone who tests positive will be required to self-isolate and take a confirmatory PCR test. The government have confirmed that anyone who has previously purchased a Randox PCR test will not need to buy another lateral flow (antigen) test.
With proven testing capability and well-established logistics and customer support services, Randox is strongly placed to allow all travellers to the UK to complete their antigen test with ease – offering same day results up to 11.59pm.
For further information on our Day 2 Lateral Flow testing please click here.
To read more on official UK government announcement please click here.
For customer enquiries please contact our Customer Support team on 028 9434 3005.
Related COVID-19 Products and Services
CERTIFLY LATERAL FLOW
HOME TEST - PCR
ANTIBODY TEST
LABORATORY TOOLS
Randox receives UKAS ISO 17025 Accreditation for testing of SARS-CoV-2 (COVID-19)
Randox receives UKAS ISO 17025 Accreditation for testing of SARS-CoV-2 (COVID-19)
Randox Laboratories has today confirmed its UKAS ISO 17025 accreditation for the detection of the SARS-CoV-2 virus (COVID-19), granted on 7th October 2021.
UKAS is the National Accreditation Body for the United Kingdom and is appointed by government to assess and accredit organisations that provide testing services. Given the unprecedented requirement for nationwide testing over the past two years, the need for the public to have confidence in testing remains more important than ever.
Randox has been at the forefront of COVID-19 testing since the outset of the pandemic, is amongst the very largest COVID-19 laboratories in the UK and Europe, and to date has processed almost 20 million tests.
Today this final UKAS documentation confirms that Randox has continuously met all ongoing Government and UKAS requirements and submission deadlines, to remain fully active as a national COVID-19 testing provider, and listed on the Gov.uk website.
Randox, with almost 40 years of diagnostics experience, and multiple UKAS accreditations for a range of testing methods, is well placed to support the testing requirements associated with international travel.
To order a Randox home test kit visit covid.randox.com
For any enquiries on our Covid testing services please contact the Randox Covid Customer Support team on +44 (0) 28 9434 3005.
Related COVID-19 Products and Services
CERTIFLY LATERAL FLOW
HOME TEST - PCR
ANTIBODY TEST
LABORATORY TOOLS
Health Minister Robin Swann visits Randox COVID testing laboratories
20th October 2021: Health Minister Robin Swann visits Randox COVID testing laboratories
Health Minister Robin Swann has today thanked local staff for their ongoing role in COVID-19 testing while visiting Randox Laboratories.
During his visit to the testing facility at Randox Science Park on the outskirts of Antrim, the Health Minister heard how the company significantly increased its testing capacity since the beginning of the pandemic.
Following a tour of the facility, Minister Swann, said: “Randox continues to play an important ongoing role in the fight against COVID-19 as part of the National Testing Programme and has enabled thousands of people in Northern Ireland to get tested quickly.
“There is no doubt, that we are in a very fortunate position in Northern Ireland to have companies like Randox. We have seen how the company and its highly skilled and expert workforce have been able to innovate and advance its testing capabilities to greatly support the pandemic. I want to personally thank the staff at Randox for all they have done in helping to keep people safe.”
Minister Swann added: “We are continuing to see a high number of positive cases each day in Northern Ireland which is concerning. Therefore I would again remind people of the importance of getting tested should they develop symptoms. Alongside vaccination and contact tracing, COVID-19 testing remains one of the main pillars of protection against this virus. Please do the right thing.”
Dr Peter FitzGerald, Randox Managing Director said:
“We are delighted to welcome Minister Swann to our COVID testing laboratories at the Randox Science Park in Antrim, to witness first-hand the incredible efforts of our hard-working staff, who have been at the forefront of COVID-19 testing since the outset of the pandemic and as such have played a vital role in the global fight against coronavirus.
“Thanks to their ongoing commitment to serve our communities in these difficult times, Randox remains amongst the very largest COVID-19 laboratories in the UK and Europe, and to date has processed almost 20 million tests for the UK National Testing Programme and testing for international travel.
“Randox have built on 40 years of diagnostic experience, and extensive R&D, to provide our extensive COVID-19 testing capabilities and we will continue to support the community and the needs of travellers for as long as that is required. Thereafter we know that diagnostics have a key role in future healthcare, to both prevent disease and optimise its treatment, and will refocus our efforts to that end.”
Since March 2020, Randox has invested a total of £150 million in the development of new innovations in testing technology and in the building and equipping of world-class testing laboratories, sample collection clinics, and associated logistics networks. The company has also grown its workforce by more than 850, and continues to recruit across science, manufacturing and customer support.
For further information please contact Amy Millar, Randox Public Relations Team Leader; amy.millar@randox.com or 028 9442 2413
Related COVID-19 Products and Services
CERTIFLY LATERAL FLOW
HOME TEST - PCR
ANTIBODY TEST
LABORATORY TOOLS
Randox launch authentication app for Day 2 Lateral Flow tests for vaccinated international arrival
18th October 2021: Randox launch authentication app for Day 2 Lateral Flow tests for vaccinated international arrivals
Randox, the UK’s largest diagnostics company, today announces that it is launching the Randox CertiFly App, a mobile application designed to securely process and certify results for both pre departure and Day 2 lateral flow tests – the latter a requirement for vaccinated international arrivals in the UK from 24th October.
The app, which applies ID verification technology, is designed to simplify foreign travel and facilitate the efficient transfer of secure and verified information through three simple steps:
Step 1 – Download the Randox CertiFly App and scan your passport to register
Step 2 – Collect your sample using a Randox CertiFly lateral flow testing kit
Step 3 – Scan your result using the app and receive certificate in app and by email
The app, which is solely for use with Randox Certifly lateral flow tests, is free to download. The lateral flow tests, which are ordered from Randox and cost as little as £20, are then used in combination with the app to capture the individual’s ID and securely upload the test result. The identity of users will be validated by scanning passports into the system, with future versions of the app featuring facial recognition software to further increase security.
Available in just 15 minutes, test results are processed using Randox CertiFly’s AI software, before being confirmed manually by a healthcare professional. As applicable, a Day 2 or fit-to-fly certificate will then be issued to the user and stored in the app for easy access.
Each Randox CertiFly lateral flow testing kit has a unique single-use QR code that can be registered with the app. Testing kits, which can be purchased from the Randox Health website, include swab, extraction buffer tube, waste bag, tube holder, package insert and test cassette. The app is available now for iOS and Android devices.
Commenting on the announcement, Dr Peter FitzGerald CBE, Managing Director at Randox, said:
“COVID-19 has severely impacted the way that we travel but, thankfully, testing technology has been able to help the world open up again. At Randox, we are proud to have been at the heart of UK testing and we are continuously looking at ways to make improvements for our customers. Randox has been helping millions of passengers travel safely since the onset of the pandemic by providing innovative testing solutions, like the Randox CertiFly app, that fulfil testing requirements for those who need to travel, whilst keeping costs as low as possible.”
Alex Rusak, Randox VP Business Development, said:
“With Day 2 lateral flow test results a requirement for vaccinated international arrivals in the UK from 24th October, we are pleased to launch our first lateral flow test certification app. The features of the app maximise security and allow the efficient flow of accurate and secure information to provide customers with a verified results certificate, without the need for time-consuming and costly video consultations. With the ability to process more than 100,000 certificates in 24h, the Randox CertiFly App rapidly provides validated test results, with the ultimate goal of making sure that travel is accessible, affordable, and importantly, safe.”
Fintan O’Rourke, Head Of Global partnerships at CertiFly, added:
“We are encouraged to see testing policy adapt to make international travelling easier and we believe that it’s crucial for technology to adapt alongside this to keep the country as safe as possible. Technology plays a vital role in ensuring the integrity of COVID-19 testing and that’s why CertiFly has developed an app with Randox to reduce the risks associated with fraudulent testing. We have built in the same verification technology that banks use to eliminate identity fraud and a two-step validation process for test results, with AI analysis followed by verification from a healthcare professional. As restrictions evolve, is it important to maintain rigorous testing standards in support of the UK’s fight against COVID-19, and we are proud to be part of this.”
The Randox Certifly App is available to download for iOS and Android devices following purchase of a lateral flow test at covid.randox.com
Related COVID-19 Products and Services
CERTIFLY LATERAL FLOW
HOME TEST - PCR
ANTIBODY TEST
LABORATORY TOOLS
Largest COVID PCR testing provider announces new nationwide network of āadaptiveā labs
Tuesday 28 September 2021: Largest COVID PCR testing provider announces new nationwide network of ‘adaptive’ labs
Randox, the UK’s largest laboratory diagnostics company, today announces its most significant expansion to date – the opening of 10 new adaptive “cube” laboratories within Great Britain. These facilities provide a rapid and cost-effective model to expand laboratory provision. They will improve accessibility to Covid testing, facilitate wider screening services and adapt to future health and testing challenges. Based on a modular format, sites can be operational within weeks and be redeployed if required.
The laboratories will initially be used to enhance the UK’s COVID-19 testing capacity during the winter, with each lab’s daily capacity of 12,000 tests combining to bring online an additional 120,000 COVID samples per day. They can subsequently be re-purposed to meet the UK’s post COVID diagnostic requirements.
The opening of the new laboratories, which upon completion, will create 700 new jobs across the UK, follows £30 million of investment by Randox, bringing its total COVID-19 investment to £150 million. Two of Randox’s ten new labs are already operational outside Manchester, with two sites to the north of London opening before the end of the month. Following this, a further six labs are set to open by the end of 2021.
Commenting on the announcement Dr Peter FitzGerald, Randox Managing Director, said;
“Whilst the initial emphasis of these new laboratories will be on providing accessible, reliable and cost-effective COVID PCR tests, we of course acknowledge the positive steps being taken to ease restrictions and continue opening up our economy.
“We can draw on what we have learnt both pre and during COVID, leveraging the extensive logistics framework and IT infrastructure we have put in place, to directly address the global shortfall in laboratory testing capacity that has been exposed by the pandemic.
“The time taken to establish the required diagnostic infrastructure in the early stages of the pandemic adversely impacted the international response, but with such an adaptable capability, the UK can, as and when needed, respond rapidly to ever-increasing diagnostic demand.”
The new adaptive laboratories from Randox will ensure the provision of travel testing for those who still require them, and can also support any surge testing for the UK’s National COVID Testing Programme; Randox has processed and reported over 18 million COVID PCR samples to date. Randox also facilitate Covid-19 lateral flow testing.
Having used its 40 years’ experience in diagnostics to focus the business towards COVID testing and support the fight against the virus, Randox, established in 1982, will subsequently use its new lab sites to service a wider UK system of walk-in clinics which can offer whole-body diagnostic screening programmes.
Dr FitzGerald continued;
“The legacy of COVID is that people increasingly understand and appreciate the importance of diagnostics and testing across our society, and as such we anticipate a real appetite from people to take greater interest in their health.
“We will continue COVID testing where necessary but will harness this high-volume testing capacity to pivot back to our core business offering of clinical health tests. The investment we have made in COVID lab facilities will allow us to build a national testing network that will facilitate a shift towards a new era of preventative healthcare, in which ill-health and disease are detected at the earliest possible opportunity, potentially even before symptoms appear.
“Our new adaptive laboratories will fundamentally be a game-changer for the UK’s future diagnostics requirements – improving patient outcomes and reducing the burden on healthcare services.”
For further information on Covid testing services please contact the Randox Covid Customer Support team on covidcustomersupport@randox.com or +44 (0) 28 9434 3005.
Want to know more?
Contact us or visit Randox Health.
Related COVID-19 Products and Services
PRE DEPARTURE
ANTIBODY TEST
DAY 2 TEST
LABORATORY TOOLS
SARS-CoV-2 Vascular & Multi-System Dysfunction Whitepaper
30 June 2021
SARS-CoV-2 Vascular & Multi-System Dysfunction Whitepaper Download
COVID-19, the disease caused by SARS-CoV-2, is an infectious disease caused by a newly discovered coronavirus. While many of whom become infected by the disease will experience mild to moderate cold or flu-like symptoms, those with health complications – such as autoimmune diseases, asthma, heart disease and diabetes – are at risk of developing serious illness and adverse outcomes.
As of September 2021, over 228 million COVID-19 cases have been confirmed worldwide, with an estimated one in six patients experiencing complications which could be life threatening, with over £116 billion spent by the UK government alone on measures to combat the disease. This drastic spending has been mirrored across the globe, with the significant economic burden expected to be suffered for generations to come.
The whitepaper provides a brief overview of the COVID-19 pandemic, before discussing vascular abnormalities and associated complications brought on by the virus, such as multi-system disfunction, acute respiratory disease syndrome (ARDS) and hepatic, renal & cardiovascular function.
Want to know more about Randox?
Contact us or visit our homepage to view more.